Douglas Roeder Biography and Net Worth

Director of Senseonics


Mr. Roeder was elected to our Board of Directors in December 2015. Mr. Roeder served on the Senseonics, Incorporated board of directors from October 2011 to December 2015. Mr. Roeder joined Delphi Ventures as an Associate in 1998, and has been a Partner of Delphi Ventures since 2000, focusing on medical devices, diagnostics and biotechnology. Prior to joining Delphi Ventures, Mr. Roeder was an Associate with Alex, Brown & Sons Healthcare Investment Banking Group. Mr. Roeder currently serves on the boards of directors of Tandem Diabetes, Inc. and several private companies. Mr. Roeder previously served on the board of directors of TriVascular Technologies, Inc. from 2008 to 2016. Mr. Roeder received his A.B. from Dartmouth College.

What is Douglas A. Roeder's net worth?

The estimated net worth of Douglas A. Roeder is at least $671.16 thousand as of November 7th, 2025. Mr. Roeder owns 99,727 shares of Senseonics stock worth more than $671,163 as of December 4th. This net worth evaluation does not reflect any other investments that Mr. Roeder may own. Learn More about Douglas A. Roeder's net worth.

How do I contact Douglas A. Roeder?

The corporate mailing address for Mr. Roeder and other Senseonics executives is 20451 Seneca Meadows Parkway, Germantown, MD 20876-7005, United States. Senseonics can also be reached via phone at 301-515-7260 and via email at [email protected]. Learn More on Douglas A. Roeder's contact information.

Has Douglas A. Roeder been buying or selling shares of Senseonics?

Over the course of the past ninety days, Douglas A. Roeder has bought $87,450.00 in shares of Senseonics stock. Most recently, on Friday, November 7th, Douglas A. Roeder bought 15,000 shares of Senseonics stock. The stock was acquired at an average cost of $5.83 per share, with a total value of $87,450.00. Following the completion of the transaction, the director now directly owns 99,727 shares of the company's stock, valued at $581,408.41. Learn More on Douglas A. Roeder's trading history.

Who are Senseonics' active insiders?

Senseonics' insider roster includes Timothy Goodnow (CEO), Sharon Larkin (Director), Douglas Roeder (Director), and Frederick Sullivan (CFO). Learn More on Senseonics' active insiders.

Are insiders buying or selling shares of Senseonics?

During the last twelve months, Senseonics insiders bought shares 5 times. They purchased a total of 52,411 shares worth more than $329,909.80. The most recent insider tranaction occured on November, 10th when Director Edelman Steven bought 10,000 shares worth more than $65,500.00. Insiders at Senseonics own 3.6% of the company. Learn More about insider trades at Senseonics.

Information on this page was last updated on 11/10/2025.

Douglas A. Roeder Insider Trading History at Senseonics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/7/2025Buy15,000$5.83$87,450.0099,727View SEC Filing Icon  
8/30/2023Buy15,000$10.80$162,000.0040,399View SEC Filing Icon  
8/25/2021Sell10,787$70.00$755,090.00View SEC Filing Icon  
5/19/2021Sell32$41.60$1,331.20View SEC Filing Icon  
4/12/2021Sell247,695$42.40$10,502,268.00View SEC Filing Icon  
4/9/2021Sell244,619$47.80$11,692,788.20View SEC Filing Icon  
6/15/2018Sell49,019$80.40$3,941,127.60View SEC Filing Icon  
6/12/2018Sell25,980$77.40$2,010,852.00View SEC Filing Icon  
See Full Table

Douglas A. Roeder Buying and Selling Activity at Senseonics

This chart shows Douglas A Roeder's buying and selling at Senseonics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Senseonics Company Overview

Senseonics logo
Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Read More

Today's Range

Now: $6.73
Low: $6.30
High: $6.89

50 Day Range

MA: $7.28
Low: $5.27
High: $11.30

2 Week Range

Now: $6.73
Low: $5.00
High: $28.00

Volume

366,949 shs

Average Volume

424,521 shs

Market Capitalization

$274.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92